CH507945A - Verfahren zur Herstellung von 1,2,3,4-Tetrahydrocarbazolderivaten und deren Verwendung - Google Patents

Verfahren zur Herstellung von 1,2,3,4-Tetrahydrocarbazolderivaten und deren Verwendung

Info

Publication number
CH507945A
CH507945A CH603368A CH603368A CH507945A CH 507945 A CH507945 A CH 507945A CH 603368 A CH603368 A CH 603368A CH 603368 A CH603368 A CH 603368A CH 507945 A CH507945 A CH 507945A
Authority
CH
Switzerland
Prior art keywords
preparation
tetrahydrocarbazole derivatives
tetrahydrocarbazole
derivatives
Prior art date
Application number
CH603368A
Other languages
English (en)
Inventor
Mooradian Aram
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc
Priority to CH1610970A priority Critical patent/CH517741A/de
Publication of CH507945A publication Critical patent/CH507945A/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
CH603368A 1967-08-10 1968-04-24 Verfahren zur Herstellung von 1,2,3,4-Tetrahydrocarbazolderivaten und deren Verwendung CH507945A (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CH1610970A CH517741A (de) 1967-08-10 1968-04-24 Verfahren zur Herstellung von 1,2,3,4-Tetrahydrocarbazolderivaten

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US65960667A 1967-08-10 1967-08-10

Publications (1)

Publication Number Publication Date
CH507945A true CH507945A (de) 1971-05-31

Family

ID=24646046

Family Applications (1)

Application Number Title Priority Date Filing Date
CH603368A CH507945A (de) 1967-08-10 1968-04-24 Verfahren zur Herstellung von 1,2,3,4-Tetrahydrocarbazolderivaten und deren Verwendung

Country Status (9)

Country Link
US (1) US3642816A (de)
JP (3) JPS509797B1 (de)
BE (1) BE714439A (de)
CH (1) CH507945A (de)
DE (1) DE1770303A1 (de)
FR (1) FR7693M (de)
GB (1) GB1225664A (de)
NL (1) NL6806044A (de)
SE (1) SE355018B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4224335A (en) * 1967-08-10 1980-09-23 Sterling Drug Inc. Tetrahydrocarbazoles and their use
US4062864A (en) * 1968-01-24 1977-12-13 Sterling Drug Inc. 3-Hydroxy carbazole derivatives
US3959309A (en) * 1968-01-24 1976-05-25 Sterling Drug Inc. 3-Amido-1,2,3,4-tetrahydrocarbazoles
GB1260768A (en) * 1969-08-28 1972-01-19 Pfizer N-alkyl-tetrahydrocarbazoles
US3920694A (en) * 1974-06-03 1975-11-18 Warner Lambert Co 4-hydroxy-9-methyl-4-vinyl-1,2,3,4-tetrahydrocarbazole
US4257952A (en) * 1977-06-06 1981-03-24 Sterling Drug Inc. 3-Amino-tetrahydrocarbazoles
US4254134A (en) * 1978-03-17 1981-03-03 Endo Laboratories, Inc. Antidepressant 2-amino- and -2-(substituted amino)-cis-hexahydro-carbazoles
DE3631824A1 (de) * 1986-02-21 1988-03-31 Bayer Ag Cycloalkano(1.2-b)indol-sulfonamide
GB9113802D0 (en) * 1991-06-26 1991-08-14 Smithkline Beecham Plc Medicaments
ES2122982T3 (es) * 1992-12-18 1999-01-01 Smithkline Beecham Plc Derivados de tetrahidrocarbazol para la fabricacion de un medicamento para el tratamiento de una enfermedad en la que esta indicado un agonista similar a 5-ht1.
EP0749962B1 (de) * 1995-06-23 2000-11-02 Eli Lilly And Company 6-Subsitituierte-1,2,3,4-tetrahydro-9H-Carbazole und 7-substituierte-1OH-Cyclohepta(7,6-B)-Indole
US5708187A (en) * 1996-06-27 1998-01-13 Eli Lilly And Company 6-substituted-1,2,3,4-tetrahydro-9H-carbazoles and 7-substituted-10H-cyclohepta 7,6-B!indoles: New 5-HT1F agonists

Also Published As

Publication number Publication date
GB1225664A (de) 1971-03-17
DE1770303A1 (de) 1971-10-07
JPS5235669B1 (de) 1977-09-10
FR7693M (de) 1970-02-23
JPS509797B1 (de) 1975-04-16
NL6806044A (de) 1969-02-12
US3642816A (en) 1972-02-15
SE355018B (de) 1973-04-02
JPS5328915B1 (de) 1978-08-17
BE714439A (de) 1968-10-30

Similar Documents

Publication Publication Date Title
CH547279A (de) Verfahren zur herstellung von 5-aroylpyrrol-derivaten und deren verwendung.
CH525224A (de) Verfahren zur Herstellung von Indolverbindungen und deren Verwendung
AT286998B (de) Verfahren zur Herstellung von neuen s-Triazinderivaten und deren Salzen
CH516519A (de) Verfahren zur Herstellung von Asparaginsäurederivaten und deren Verwendung
AT284819B (de) Verfahren zur Herstellung von neuen Amino-monohalogenphenyläthanolaminen und von deren Salzen
CH507945A (de) Verfahren zur Herstellung von 1,2,3,4-Tetrahydrocarbazolderivaten und deren Verwendung
AT286992B (de) Verfahren zur Herstellung von Pyrimidinderivaten und von deren Salzen
CH530396A (de) Verfahren zur Herstellung von N-Phenylindolinderivaten und deren Verwendung
CH499481A (de) Verfahren zur Herstellung von a,a-Diacyloxy-2,3,4,5,6-pentachlortoluolderivaten und Verwendung derselben in Fungiziden
CH554896A (de) Verfahren zur herstellung von p-nitrobenzyl-desacetoxycephalosporinestern und deren verwendung.
CH539009A (de) Verfahren zur Herstellung von Hydroxyverbindungen und deren Verwendung
CH532031A (de) Verfahren zur Herstellung von in 2-Stellung substituierten 5-Nitro-furan-, 5-Nitro-thiophen- und 5-Nitro-pyrrolderivaten
CH513947A (de) Verfahren zur Herstellung von Farbstoffen und Verwendung derselben
CH524623A (de) Verfahren zur Herstellung von Triazaadamantan-Derivaten und deren Verwendung
CH532559A (de) Verfahren zur Herstellung von Sulfamylbenzoesäure-Derivaten und deren Verwendung
CH521943A (de) Verfahren zur Herstellung von Aminophenolen und deren Verwendung
CH554344A (de) Verfahren zur herstellung von 5-phenylbenzomorphanderivaten und deren salzen.
AT289123B (de) Verfahren zur Herstellung von Pyrazinamidderivaten und von deren Salzen
CH541608A (de) Verfahren zur Herstellung von Nitrodiphenylaminen und deren Verwendung
CH485666A (de) Verfahren zur Herstellung von Niederalkyl-a-carboalkoxy-B-(3-niederalkyl-4-niederalkoxy-anilino)--acrylaten und deren Verwendung zur Herstellung von entsprechenden Chinolaten
CH522578A (de) Verfahren zur Herstellung von Ketonen und deren Verwendung
CH481881A (de) Verfahren zur Herstellung von Fluoracetyla minotrichlormethylmethan-Derivaten und deren Verwendung
AT311563B (de) Verfahren zur Herstellung von neuen 18-Nor-14β-pregnano-[13,14-f]-hexahydro-1,4-oxazepinen und von deren Salzen
AT296974B (de) Verfahren zur Herstellung von neuen 2,3-Dihydro-5H-imidazo[2,1-a]isoindolderivaten und ihren Salzen
CH493545A (de) Verfahren zur Herstellung von Derivaten von 1,2,3,4-Tetrahydro-5H-pyrido-(4,3b)-indolen

Legal Events

Date Code Title Description
PL Patent ceased